Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 3576
Gene Symbol: CXCL8
CXCL8
0.100 Biomarker phenotype BEFREE In the gut and lungs, IA LPS-induced inflammatory responses were observed mainly at birth (increased LPS, CXCL8, and IL-1β levels and myeloperoxidase-positive cell density, multiple increases in innate immune gene expressions, and reduced villus heights), but not on postnatal day 5 (except elevated lung CXCL8 and diarrhea symptoms). 30314768 2018
Entrez Id: 3576
Gene Symbol: CXCL8
CXCL8
0.100 GeneticVariation phenotype BEFREE The results showed a weak association between the IL-8 AA genotype and OIs such as STDs (P = 0.143), diarrhea (P = 0.906), and TB (P = 0.762). 26985957 2016
Entrez Id: 3576
Gene Symbol: CXCL8
CXCL8
0.100 Biomarker phenotype BEFREE In a 2009 outbreak of C. difficile-associated diarrhea that was recorded in a major Costa Rican hospital, the hypervirulent NAP1 strain (45%) predominated together with a local genotype variant (NAPCR1, 31%). 27165560 2016
Entrez Id: 3576
Gene Symbol: CXCL8
CXCL8
0.100 AlteredExpression phenotype BEFREE The aim of this study was to compare virulence properties, including the phylogenetic groups, afa subtypes, IL-8 secretion levels, and the effects on tight junctions, of DAEC strains isolated from healthy persons with those isolated from patients with diarrhoea. 23068272 2013
Entrez Id: 3576
Gene Symbol: CXCL8
CXCL8
0.100 Biomarker phenotype BEFREE The dominant 072 ribotype was carried by 43% (12/28) of subjects, while the hypervirulent strain R027 (B1/NAP1/027) was isolated from 3 subjects (11%), 2 of whom displayed C. difficile associated diarrhea (CDAD) symptoms at the time of sampling. 22162545 2012
Entrez Id: 3576
Gene Symbol: CXCL8
CXCL8
0.100 Biomarker phenotype BEFREE ELISA analysis was further confirmed that Lb. crispatus K243 and K313 inhibited the IL-8 secretion triggered by S. braenderup H9812 by 32.8% and 47.0%, indicating that the two isolates could attenuate the pro-inflammatory signaling induced by S. braenderup H9812, and have the potential application in clinical practice to prevent diarrhea. 22542524 2012
Entrez Id: 3576
Gene Symbol: CXCL8
CXCL8
0.100 Biomarker phenotype BEFREE The X-DING-CD4-mediated inhibition of the IL-8 promoter also resulted in a reduction of the soluble IL-8 protein in endothelial cells and human macrophages infected with a subset of enteric bacteria frequently causing diarrhea in progressive HIV disease. 22031506 2012
Entrez Id: 3576
Gene Symbol: CXCL8
CXCL8
0.100 Biomarker phenotype BEFREE Fecal IL-8 concentration for the single antibody-positive CDAD subject with AA genotype was lower than the median level of 822 microg/mL seen in 10 anti-toxin A antibody-negative subjects with CDAD. 17618838 2007
Entrez Id: 3576
Gene Symbol: CXCL8
CXCL8
0.100 GeneticVariation phenotype BEFREE Fecal IL-8 production and single nucleotide polymorphism (SNP) frequency in the -251 region of the IL-8 gene were determined in hospitalized patients: 42 with CDD, 42 with CD-negative diarrhea, and 41 without diarrhea. 16573784 2006
Entrez Id: 3576
Gene Symbol: CXCL8
CXCL8
0.100 GeneticVariation phenotype BEFREE A polymorphism in the IL-8 gene promoter is associated with susceptibility to diarrhea due to enteroaggregative Escherichia coli. 16258326 2005
Entrez Id: 3576
Gene Symbol: CXCL8
CXCL8
0.100 AlteredExpression phenotype BEFREE In the present study, the AA genotype at the -251 position was associated with the occurrence of EAEC-associated diarrhea and increased levels of fecal IL-8. 12898436 2003
Entrez Id: 3576
Gene Symbol: CXCL8
CXCL8
0.100 GeneticVariation phenotype LHGDN Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region. 12898436 2003
Entrez Id: 3576
Gene Symbol: CXCL8
CXCL8
0.100 Biomarker phenotype BEFREE The presence of aggR or one or more virulence factors in EAEC from patients with diarrhea was associated with a statistically increased concentration of interleukin-8 (IL-8) in feces compared with that in EAEC negative for these factors: for aggR positive (9 of 12 [75%]; median, 800 pg/ml) versus aggR negative (5 of 18 [28%]; median, 0), P < 0.05; and for isolates positive for > or =1 virulence factor (13 of 21 [62%]; median, 360 pg/ml) versus those negative for > or =1 virulence factor (1 of 9 [11%]; median, 0), P < 0.05. 12409395 2002